RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 133 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,774,916 | +140.1% | 10,689,532 | +134.4% | 0.01% | +133.3% |
| Q2 2023 | $34,060,188 | -46.3% | 4,559,597 | -52.1% | 0.00% | 0.0% |
| Q1 2023 | $63,437,846 | +84.2% | 9,510,922 | +113.0% | 0.00% | 0.0% |
| Q4 2022 | $34,430,661 | -23.9% | 4,465,715 | +5.0% | 0.00% | -40.0% |
| Q3 2022 | $45,233,000 | +95.9% | 4,251,164 | +49.9% | 0.01% | +150.0% |
| Q2 2022 | $23,084,000 | +50.3% | 2,835,852 | +32.2% | 0.00% | +100.0% |
| Q1 2022 | $15,363,000 | -41.4% | 2,145,639 | +40.2% | 0.00% | -50.0% |
| Q4 2021 | $26,213,000 | -41.9% | 1,530,226 | -21.9% | 0.00% | -50.0% |
| Q3 2021 | $45,099,000 | -44.1% | 1,959,963 | -11.4% | 0.00% | -33.3% |
| Q2 2021 | $80,724,000 | – | 2,211,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |